Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Silo Pharma, Inc. reports that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC may each be deemed to beneficially own 176,165 shares as of September 30, 2026, representing approximately 9.99% of the common stock. The reported position comprises 994 shares held by Intracoastal and shares issuable upon exercise of four warrants.
The ownership calculation uses 1,588,250 shares outstanding as of August 13, 2026, plus warrant shares. Exercise blockers exclude additional warrant shares from the reported amount: two warrants have 9.99% limits and two have 4.99% limits. Without those blockers, each reporting person may have been deemed to beneficially own 637,299 shares.
Key Figures
Beneficially owned:176,165 sharesPercentage of common stock:Approximately 9.99%Common shares outstanding:1,588,250 shares+4 more
7 metrics
Beneficially owned176,165 sharesEach reporting person may have been deemed to own this amount as of September 30, 2026
Percentage of common stockApproximately 9.99%Reported beneficial ownership as of September 30, 2026
Common shares outstanding1,588,250 sharesAs of August 13, 2026, as reported by Silo Pharma, Inc.
Common shares held994 sharesHeld by Intracoastal Capital LLC
Shares issuable under Warrants 1–455,556; 55,556; 63,492; and 567 shares, respectivelyIntracoastal Capital LLC warrants included in reported beneficial ownership
Beneficial ownership without blocker provisions637,299 sharesAmount each reporting person may have been deemed to own without the warrant blocker provisions
Warrant exercise blocker limits9.99% and 4.99%Warrants 4 and 5 use 9.99% limits; Warrants 6 and 7 use 4.99% limits
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
blocker provisionfinancial
"contains a blocker provision"
shared voting powerregulatory
"Shared Voting Power 176,165.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shares issuable upon exercisefinancial
"shares of Common Stock issuable upon exercise of a warrant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Silo Pharma shares do the reporting persons beneficially own?
Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC may each be deemed to beneficially own 176,165 shares, or approximately 9.99% of the common stock, as of September 30, 2026. The amount includes shares held by Intracoastal and shares issuable upon exercise of warrants.
How do warrant exercise blockers affect reported SILO ownership?
Two warrants restrict exercise that would result in beneficial ownership above 9.99%, and two use a 4.99% limit. The excluded amounts are 206,088 shares under Warrant 4, 206,655 under Warrant 5, 22,936 under Warrant 6 and 25,455 under Warrant 7. Without the blockers, each reporting person may have been deemed to own 637,299 shares.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 5)
Silo Pharma, Inc.
(Name of Issuer)
Common stock, par value $0.0001 per share
(Title of Class of Securities)
82711P300
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
82711P300
1
Names of Reporting Persons
Mitchell P. Kopin
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
176,165.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
176,165.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
176,165.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
82711P300
1
Names of Reporting Persons
Daniel B. Asher
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
176,165.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
176,165.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
176,165.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
CUSIP Number(s):
82711P300
1
Names of Reporting Persons
Intracoastal Capital LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
176,165.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
176,165.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
176,165.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Silo Pharma, Inc.
(b)
Address of issuer's principal executive offices:
677 N. Washington Boulevard, Sarasota, FL 34236
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)
Address or principal business office or, if none, residence:
The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)
Citizenship:
Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)
Title of class of securities:
Common stock, par value $0.0001 per share
(e)
CUSIP No.:
82711P300
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on September 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 176,165 shares of Common Stock, which consisted of (i) 994 shares of Common Stock held by Intracoastal, (ii) 55,556 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), (iii) 55,556 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2"), (iv) 63,492 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3") and (v) 567 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 1,588,250 shares of Common Stock outstanding as of August 13, 2026, as reported by the Issuer, plus (2) 55,556 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, (3) 55,556 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, (4) 63,492 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 and (5) 567 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4. The foregoing excludes (I) 206,088 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4 because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 206,655 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal ("Intracoastal Warrant 5") because Intracoastal Warrant 5 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 5 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (III) 22,936 shares of Common Stock issuable upon exercise of a sixth warrant held by Intracoastal ("Intracoastal Warrant 6") because Intracoastal Warrant 6 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 6 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (IV) 25,455 shares of Common Stock issuable upon exercise of a seventh warrant held by Intracoastal ("Intracoastal Warrant 7") because Intracoastal Warrant 7 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 7 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 637,299 shares of Common Stock.
(b)
Percent of class:
9.99 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
176,165
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
176,165
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
